Access to medicine; memorial service

Cheaper drugs for developing countries

The IPKat apologies for having missed the fact that GSK has announced that it will cut drug prices in 50 countries in the developing world (reported here in the BBC). Patented formulas and processes owned by GSK under patent will be shared with researchers. GSK will also reivest 20% of the firm's profits in the developing world in hospitals and clinics there.

The IPKat welcomes this announcement. Yes, a patent can be used in any way its owner wants, and yes it can be used to gain a monopoly rent, but a patent owner also has the right to use his patent in an altruistic way. GSK has raised the game here and the IPKat wonders whether competitors will follow suit.


The IPKat draws his readers' notice to the following announcement:
LADDIE, Hugh Ian Lang, a Thanksgiving for
the Life and Work of Professor Sir Hugh Laddie
will take place at Middle Temple Hall, EC4 9AT
on 4 March 2009 at 6pm. Reception follows.
Access to medicine; memorial service Access to medicine; memorial service Reviewed by Unknown on Wednesday, February 18, 2009 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here:

Powered by Blogger.